In this webinar hosted from EMMA International’s Solutions Delivery Specialist, Nikita Angane, she will go over the different FDA Centers, as well as the pathways to market, what a RTA (Refuse to Accept) is, and also reviewing labeling, registration, and device listings.
Alzheimer’s disease is the most common cause of dementia, especially in patients aged 65 and older1. Alzheimer’s ...
